No Trial Details Found
-
Clinicaltrials. gov Identifier
-
Recruitment Status
-
First Posted
-
Result First Posted
-
Last Update Posted
Content
- Study Details
- Study Results
Study Description
Brief Summary
The CUV104 study will assess the efficacy
and safety of afamelanotide in patients with vitiligo on the face and body as a monotherapy
in repigmentation.
Condition or Disease
Vitiligo
Intervention/Treatment
Afamelanotide
Phase
Detailed Description
N/A
Study Design
Study Type
Enrollment
Allocation
Intervention Model
Masking
Primary Purpose
Official Title
Estimated Study Start Date
Estimated Primary Completion Date
Estimated Study Completion Date
Arms & Interventions
Arm
Intervention
Outcome Measures
Primary Outcome Measures
Secondary Outcome Measures
Other Outcome Measures
Eligibility Criteria
Ages Eligible for Study
18 to 75 Years (Adult, Older Adult)T
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Criteria
Inclusion Criteria
Exclusion Criteria
Contacts & Locations
Contacts
Head of Clinical Operations
+441372860765 mail@clinuvel.com
+441372860765 mail@clinuvel.com
Locations
United States, Michigan CLINUVEL Investigational site Detroit
Sponsors and Collaborators
Investigators
More Information
Responsible Party
Interventional
ClinicalTrials.gov Identifier
Other Study ID Numbers
First Posted
Last Update Posted
Last Verified
Individual Participant Data (IPD) Sharing Statement
Plan to Share IPD
Studies a U.S. FDA-regulated Drug
Product
Product
Studies a U.S. FDA-regulated Device
Product
Product
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH Terms